| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82317c98745e29636e6af1c724ed9586 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 |
| filingDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d61d0f62f2bccc4c89bf7e5e84410272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e3ac04319f262b95a8b72c3b0dbfe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bb15c482ad7e519ed5f1dd274208e8c |
| publicationDate |
2006-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7108869-B2 |
| titleOfInvention |
Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| abstract |
A nutritional supplement composition contains inhibitors of alpha-glucosidase and alpha-amylase substantially in the absence of lipase inhibitors. The composition can include touchi extract and phaseolamin as the alpha-glucosidase and alpha-amylase inhibitor, respectively. A method of limiting the absorption of carbohydrates contained in a foodstuff includes administering the nutritional supplement composition prior to consumption of the carbohydrates, and a method of promoting weight loss in an individual includes administering the nutritional supplement composition to the individual over a period of days. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010029581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815312-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012276081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009148545-A1 |
| priorityDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |